Health & Nutrition

bg
Grindr expands beyond dating with $250 million telehealth acquisition of PurposeMed

Grindr expands beyond dating with $250 million telehealth...

Grindr is buying PrEP provider Freddie for $250 million, expanding into healthcare...

bg
People switching to Novo's Wegovy pill from obesity injections kept losing weight in real-world study 

People switching to Novo's Wegovy pill from obesity injections...

The data on Novo's Wegovy pill suggests that patients may not need to take weekly...

bg
How Much Do New Chemotherapy Drugs Extend Life?

How Much Do New Chemotherapy Drugs Extend Life?

If you put together all the new chemotherapy drugs approved over a dozen years,...

bg
White House moves to block $810 million in funding through pocket rescission

White House moves to block $810 million in funding through...

The White House is moving to block $810 million in appropriated funds days before...

bg
NIH funding cuts delayed a promising childhood brain cancer trial. Patients lost time they didn't have

NIH funding cuts delayed a promising childhood brain cancer...

A delayed clinical trial underscores the stakes of federal research funding cuts...

bg
Novo is betting on its next chapter as Eli Lilly gains more ground in GLP-1s

Novo is betting on its next chapter as Eli Lilly gains...

As Novo works to turn itself around, some analysts say Lilly has advantages that...

bg
NIH funding cuts delayed a promising childhood brain cancer trial. Patients lost time they didn't have.

NIH funding cuts delayed a promising childhood brain cancer...

A delayed clinical trial underscores the stakes of federal research funding cuts...

bg
Why we like Starbucks’ latest turnaround move — plus, two more wins for Eli Lilly

Why we like Starbucks’ latest turnaround move — plus, two...

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon...

bg
Chemotherapy Is Expensive—Is It Effective?

Chemotherapy Is Expensive—Is It Effective?

Most chemotherapy drugs are approved by the U.S. Food and Drug Administration (FDA)...

bg
Novo's new strategy hinges on something it can't manufacture: investor trust

Novo's new strategy hinges on something it can't manufacture:...

Novo has now reached the point where it can broaden its ambitions again, CEO Mike...